Zacks Investment Research upgraded shares of National Health Investors (NYSE:NHI) from a sell rating to a hold rating in a research report report published on Thursday, Zacks.com reports.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Separately, ValuEngine downgraded National Health Investors from a hold rating to a sell rating in a research report on Wednesday, October 2nd. Three investment analysts have rated the stock with a sell rating and three have assigned a hold rating to the company’s stock. The stock currently has a consensus rating of Hold and an average price target of $79.60.

NHI traded up $0.72 during trading on Thursday, reaching $84.29. 152,006 shares of the stock were exchanged, compared to its average volume of 189,598. The business’s 50 day moving average price is $82.96 and its two-hundred day moving average price is $79.87. The company has a debt-to-equity ratio of 1.04, a current ratio of 14.42 and a quick ratio of 14.42. The company has a market capitalization of $3.62 billion, a price-to-earnings ratio of 15.38, a P/E/G ratio of 3.81 and a beta of 0.29. National Health Investors has a 1 year low of $72.15 and a 1 year high of $84.75.

National Health Investors (NYSE:NHI) last posted its earnings results on Thursday, August 8th. The real estate investment trust reported $0.92 EPS for the quarter, missing the Zacks’ consensus estimate of $1.37 by ($0.45). The firm had revenue of $78.10 million for the quarter, compared to analysts’ expectations of $77.64 million. National Health Investors had a return on equity of 11.00% and a net margin of 50.71%. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.38 earnings per share. On average, analysts anticipate that National Health Investors will post 5.49 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Monday, September 30th will be given a dividend of $1.05 per share. The ex-dividend date is Friday, September 27th. This represents a $4.20 dividend on an annualized basis and a yield of 4.98%. National Health Investors’s payout ratio is 76.64%.

In other news, Director James R. Jobe sold 900 shares of the business’s stock in a transaction on Tuesday, September 24th. The stock was sold at an average price of $83.23, for a total value of $74,907.00. Following the completion of the transaction, the director now directly owns 12,052 shares of the company’s stock, valued at $1,003,087.96. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 5.11% of the stock is currently owned by insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in NHI. Tuttle Tactical Management purchased a new stake in shares of National Health Investors in the third quarter worth about $818,000. Envestnet Asset Management Inc. boosted its position in shares of National Health Investors by 8.2% in the third quarter. Envestnet Asset Management Inc. now owns 7,885 shares of the real estate investment trust’s stock worth $650,000 after buying an additional 600 shares during the period. Nisa Investment Advisors LLC boosted its position in shares of National Health Investors by 39.9% in the third quarter. Nisa Investment Advisors LLC now owns 25,217 shares of the real estate investment trust’s stock worth $2,078,000 after buying an additional 7,187 shares during the period. Navellier & Associates Inc boosted its position in shares of National Health Investors by 26.7% in the third quarter. Navellier & Associates Inc now owns 9,440 shares of the real estate investment trust’s stock worth $778,000 after buying an additional 1,987 shares during the period. Finally, Stock Yards Bank & Trust Co. purchased a new stake in shares of National Health Investors in the third quarter worth about $206,000. 69.70% of the stock is owned by institutional investors.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Story: How to read a candlestick chart

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.